Results 171 to 180 of about 2,311,382 (303)

Feasibility of Using <i>Tenebrio molitor</i> Larvae as an Alternative Protein Source. [PDF]

Foods
Agregán R, Echegaray N, Moraga-Babiano L, Pateiro M, Lorenzo JM.   +4 more
europepmc   +1 more source

6: Alternative proteins

Insects; Plant-based meat; Cultured meat; Cultivated meat; Cellular ...
de Amstalden, Mariela, Stephens, Neil
openaire   +2 more sources

Somatic mutational landscape in von Hippel–Lindau familial hemangioblastoma

Molecular Oncology, EarlyView.
The causes of central nervous system (CNS) hemangioblastoma in Von Hippel–Lindau (vHL) disease are unclear. We used Whole Exome Sequencing (WES) on familial hemangioblastoma to investigate events that underlie tumor development. Our findings suggest that VHL loss creates a permissive environment for tumor formation, while additional alterations ...
Maja Dembic, Anne Nørremølle, Lilian Bomme Ousager, Lars van Brakel Andersen, Marie Louise Mølgaard Binderup, Mads Thomassen   +5 more
wiley   +1 more source

Pumpkin Seed Proteins: The Potentially Alternative Protein Supplements for Food Applications. [PDF]

Foods
Xie Y, Wang Y, Jin X, Zhang X, Yang R.
europepmc   +1 more source

Establishment of a humanized patient‐derived xenograft mouse model of high‐grade serous ovarian cancer for preclinical evaluation of combination immunotherapy

Molecular Oncology, EarlyView.
We have established a humanized orthotopic patient‐derived xenograft (Hu‐oPDX) mouse model of high‐grade serous ovarian cancer (HGSOC) that recapitulates human tumor–immune interactions. Using combined anti‐PD‐L1/anti‐CD73 immunotherapy, we demonstrate the model's improved biological relevance and enhanced translational value for preclinical ...
Luka Tandaric, Line Bjørge, Martine Rott Lode, Cecilie Fredvik Torkildsen, Pia Aehnlich, Rammah Elnour, Daniela Elena Costea, Lars Andreas Akslen, Liv Cecilie Vestrheim Thomsen, Emmet McCormack, Katrin Kleinmanns   +10 more
wiley   +1 more source

Public discourses of alternative protein foods in Facebook public pages' posts, 2014-2024. [PDF]

PLoS One
Zhang W, Wang B, Xie J, Leong LP, Leong TWD, Tham MJR, Ang WH.   +6 more
europepmc   +1 more source

Hippo pathway at the crossroads of stemness and therapeutic resistance in breast cancer

Molecular Oncology, EarlyView.
Dysregulation of the Hippo pathway drives nuclear accumulation of YAP/TAZ, activating stemness‐related transcriptional programs that sustain breast cancer stemness and fuel therapeutic resistance across subtypes, underscoring Hippo signaling as a targetable vulnerability. Figure created and edited with BioRender.com.
Giulia Schiavoni, Antonella Palmese, Stefano Scalera, Laura Cipriani, Davide Mascolo, Patrizia Vici, Teresa Arcuri, Lorena Filomeno, Eriseld Krasniqi, Giovanni Blandino, Giulia Bon, Marcello Maugeri‐Saccà   +11 more
wiley   +1 more source

Exploring Sustainable Diet Drivers: An Extended TPB Approach to Alternative Protein Acceptance in Southern Italy. [PDF]

Nutrients
Civero G, Punzo G, Scarpato D.
europepmc   +1 more source

Differential expression of cancer‐related genes supports prediction of poor response to first‐line treatments in T‐ALL pediatric patients with high minimal residual disease

Molecular Oncology, EarlyView.
In the present work, we have identified a transcriptional signature based on the differential expression of six genes (BCL2&MAST4, HSH2D&LAT2, METRN&PITPNM2) that would facilitate the early detection of T‐cell acute lymphoblastic leukemia (T‐ALL) patients prone to a poor treatment response and could be implemented at diagnosis, along with other risk ...
Antonio Lahera, Laura Vela‐Martín, Pablo Fernández‐Navarro, José Luis López‐Lorenzo, Javier Cornago, Pilar Llamas, Eduardo Pérez‐Gómez, José Luis Marín‐Rubio, Manuel Fresno, Javier Santos, José Fernández‐Piqueras, María Villa‐Morales   +11 more
wiley   +1 more source

Evaluation of Alternative Protein and Lipid Sources for Rainbow Trout (<i>Oncorhynchus mykiss</i>): Growth, Fillet Quality, and Economic Outcomes of a Farm-Based Diet. [PDF]

Animals (Basel)
Roncarati A, Galosi L, Dell'Unto D, Bottoni MPF, Quagliardi M, Antenucci E, Iaffaldano N, Cortignani R, Danieli PP.   +8 more
europepmc   +1 more source